Обзор и прогноз мирового рынка гелей для ран до 2031 года — анализ рынка и доля рынка

Обзор мирового рынка гелей для ран

Гели для ран имеют решающее значение в уходе за ранами, в первую очередь, они сделаны из значительного количества воды, чтобы поддерживать влажную среду заживления. Они облегчают газообмен и регенерацию тканей, что имеет решающее значение для эффективного заживления. Например, гидрогели, состоящие из полиакриламида и агара, поддерживают вашу кожу увлажненной, предлагая гладкую, эластичную и прозрачную поверхность. Современные гели для ран часто включают в себя биоактивные ингредиенты, такие как противомикробные препараты , факторы роста и стволовые клетки, чтобы улучшить заживление, предотвращая инфекцию и усиливая естественные процессы восстановления организма. Это нововведение стимулирует рост на рынке гелей для ран.

Отчет по исследованию рынка Data Bridge Market содержит сведения о последних событиях, правилах торговли, доле рынка, тенденциях рынка на основе сегментации и регионального анализа, влиянии участников рынка, анализе возможностей с точки зрения новых источников дохода, правилах рынка, стратегическом анализе роста рынка, размере рынка, росте рынка по категориям, нишах приложений и доминировании, одобрении продуктов, запуске продуктов, географическом расширении и технологических инновациях на рынке. Чтобы получить больше информации о рынке, свяжитесь с командой экспертов-аналитиков Data Bridge Market Research. Наша команда поможет вам принять обоснованные рыночные решения для достижения роста бизнеса.

Размер мирового рынка гелей для ран

As the population ages and the incidence of chronic diseases such as diabetes rises, the number of individuals suffering from hard-to-heal wounds is expected to increase substantially. This growing patient population will require advanced wound care products to promote healing, prevent complications, and improve quality of life. Wound gels, which provide a moist healing environment while delivering active ingredients to the wound bed, are a critical component of the treatment for many acute and chronic wounds. Manufacturers are expected to scale up the production of wound gels to meet the rising demand for effective wound care. Additionally, they will need to invest more in research and development to bring innovative products to market. Distributors and healthcare providers will also need to ensure adequate supplies of wound gels to meet the needs of the expanding population of patients with chronic wounds. Databridge Market Research took a dive into comprehensively analyzing the market and unveiled that the global wound gel market is increasing at a CAGR of 6.10%. The size of the market is valued at USD 22.51 billion in 2023 and is expected to grow up to USD 36.16 billion by 2031.

Wound Gel Market Dynamics

Wound Gel Market Growth Drivers

Rising Incidence of Surgical Procedures

The rising incidence of surgical procedures significantly impacts the growth of the wound gel market. As surgical operations increase globally, the associated risks of complications, particularly surgical site infections (SSIs), have also risen. Studies show that surgical site infections (SSIs) can occur in up to 2% of surgical cases that results in longer hospital stays and higher healthcare costs, with an average additional expense of $18,626 per infection for Medicare patients. This financial burden, coupled with the heightened awareness of patient safety and recovery outcomes, drives demand for advanced wound care products, including wound gels. These gels are essential in surgical settings where the risk of SSIs is high, as they help to promote healing and prevent infections. Furthermore, with the trend towards minimally invasive surgeries, which often require specialized wound care solutions, the wound gel market is expected to expand as healthcare providers seek effective ways to manage surgical wounds and enhance patient recovery.

Growing Awareness and Education

The growing awareness and education surrounding wound care is an important factor drives the expansion of the wound gel market. As healthcare organizations and wound care associations launch educational campaigns, they effectively spread crucial information about the risks associated with improper wound management and the benefits of advanced wound care products. This increased awareness is crucial due to the growing incidence of chronic wounds, particularly among the elderly and those with conditions such as diabetes. This highlights the critical need for effective wound care solutions. Additionally, the advancement of innovative and user-friendly wound care products has made it easier for patients to manage their wounds at home that leading to increased adoption and awareness of their effectiveness. As awareness of the significance of proper wound care increases, the demand for advanced wound gels and related products is anticipated to rise. This growing awareness will drive the market forward, enabling individuals to effectively manage their wounds.

Increase in the Number of Burn Cases

The increase in burn cases significantly drives the growth of the wound gel market, particularly for advanced treatments such as hydrogel dressings. According to World Health Organization, around 180,000 burn-related deaths are estimated annually and over 500,000 individuals in the U.S. seeking treatment each year, the prevalence of burn injuries creates a substantial demand for effective wound care solutions. Wound gels are increasingly favored due to their unique properties, which provide a moist healing environment, reduce pain, and protect wounds from contamination. Their ability to incorporate therapeutic agents further enhances healing and infection prevention that makes them a preferred choice for both clinicians and patients. Ongoing advancements in burn care, such as the creation of new hydrogel formulations with enhanced moisture retention and antimicrobial properties, are essential for effectively managing the challenges associated with severe burn injuries. As healthcare providers focus on improving patient outcomes, the increasing prevalence of burn injuries is driving demand for advanced wound care products. This trend is prompting manufacturers to invest more in research and development that improves treatment efficacy and reducing complications associated with burn wounds.

Global Wound Gel Market Growth Opportunities

The wound gel market is expected for significant growth in the coming years, driven by the expansion of healthcare infrastructure in emerging economies. The demand for specialized wound care products such as wound gels, is expected to rise due to enhanced capabilities and accessibility of healthcare facilities. Improved infrastructure facilitates the distribution of these products and encourages healthcare providers to adopt advanced solutions necessary for effectively managing complex wounds. Furthermore, increased healthcare spending by governments and private entities will enable the procurement of high-quality wound care products that provides better long-term outcomes. This shift towards value-based care emphasizes the importance of investing in advanced wound care solutions, thereby creating a favorable environment for the wound gel market to grow.

Wound Gel Market Size Growth Challenges

The financial burden on the wound gel market presents significant challenges that can hinder its growth and expansion. The high development costs associated with research, clinical trials, and regulatory compliance affects the smaller firms and startups that may lack the financial resources. Additionally, the high prices of advanced wound gels render them less accessible in price-sensitive healthcare environments that leads to slower adoption rates among consumers and healthcare providers. This price sensitivity is exacerbated by competition from more affordable alternative treatments, which may lead healthcare providers to choose less expensive options that limits the market potential for wound gels. Limited financial resources hinder efforts to raise awareness and demonstrate the value of these products which makes it difficult for companies to effectively market their innovations and educate potential users about their benefits.

Wound Gel Market Size Growth Restraints   

The side effects due to wound gels, especially those containing active ingredients such as silver or antibiotics, significantly hinder the market growth of these products. Adverse reactions such as skin irritation, allergic reactions, and the development of antibiotic resistance can limit their use and acceptance among healthcare providers and patients. For instance, while silver-based wound gels are effective in preventing infections, they can also lead to argyria, a condition where silver accumulates in the body that causes a bluish-gray discoloration of the skin. Additionally, the overuse of antibiotic-infused gels can contribute to the growing problem of antibiotic resistance which makes infections harder to treat. Furthermore, the potential for adverse effects can lead to increased regulatory scrutiny and the need for extensive clinical trials that further complicates the development and approval processes for new wound gel formulations. As a result, the combination of safety concerns, regulatory challenges, and the need for ongoing education about proper use limits the wound gel market growth.

Wound Gel Market Scope and Trends

• Amorphous hydrogels, such as EHO-85, are designed to maintain optimal moisture levels in the wound bed.
• Amorphous hydrogels facilitate autolytic debridement, which helps in the removal of necrotic tissue while keeping the wound moist and warm.
• Aurix Gel is a type of wound gel which provides an effective treatment for chronic diabetic foot ulcers due to its unique formulation that promotes faster tissue repair and recovery and reduces inflammation.
• Venous leg ulcers are persistent skin wounds due to poor blood circulation from venous insufficiency that affects up to 2% of people and often recurring in 50-70% of cases within six months.
• Wound gels help venous leg ulcers to heal by maintaining a moist environment and reducing infection risk.

Wound Gel Market Regional Analysis – Market Trends

Key Insights

• The U.S. dominates the North American market due to technological advancements and the presence of major players.
• Строгие экологические нормы и внимание к безопасности работников способствуют внедрению автоматических систем смазки в Европе.
• Закон Европейской комиссии о промышленности с нулевыми выбросами направлен на установление целевых показателей промышленного потенциала ЕС с упором на упрощение нормативно-правовой базы для основных технологий.
• Германия лидирует на европейском рынке, в то время как Великобритания демонстрирует быстрый рост, что подчеркивает региональные различия в динамике рынка.
• На долю Германии приходится почти 20% европейского рынка автоматических систем смазки.
• Строительный сектор Китая, вклад которого в ВВП страны составляет до 6%, является значимым драйвером рынка автоматических систем смазки в Азиатско-Тихоокеанском регионе.

Ведущие игроки на рынке гелей для ран

• Смит+Нейфью (Великобритания)
• Mölnlycke Health Care AB (Швеция)
• Бакстер (США)
• 3M (США)
• Integra LifeSciences (США)
• ConvaTec Group Plc (Великобритания)
• Coloplast A/S (Дания)
• Medtronic (Ирландия)
• PAUL HARTMANN AG (Германия)
• MiMedx (США)
• DeRoyal Industries Inc., (США)
• Organogenesis Inc., (США)
• Керечис (Исландия)
• ACell Inc., (США)
• Lohmann & Rauscher GmbH & Co. KG (Германия)
• Medela AG (Швейцария)
• Talley Group (Англия)
• Pensar Medical LLC (США)
• Б. Браун Мельсунген АГ (Германия)
• Cardinal Health (США)
• Bioventus LLC. (США)
• Zimmer Biomet (США)
• DermaRite Industries LLC (США)
• Medline Industries Inc., (США)
• Brightwake Ltd (Великобритания)
• MilLaboratories Pvt. Ltd. (Индия)
• Welcare Industries Spa. (Италия)
• Haromed BVBA (Бельгия)

Последние события на рынке гелей для ран

• В январе 2023 года компания Convatec Group выпустила ConvaFoam — универсальную повязку, подходящую для различных типов ран, что расширяет возможности ее применения при лечении ран.
• В сентябре 2022 года компания MiMedx Group представила AMNIOEFFECT — трехслойный аллотрансплантат человеческой ткани, предназначенный для улучшения результатов заживления сложных ран.
• В марте 2024 года компания Sanara MedTech объявила о значительных достижениях и стратегических планах во время своих финансовых конференций, последнее обновление:
• В феврале 2020 года компания Integra LifeSciences выпустила AmnioExcel Plus Placental Allograft Membrane — продукт нового поколения для ухода за ранами. Он имеет более толстую трехслойную структуру из амниона, хориона и амниона для поддержки восстановления мягких тканей и использует технологию DryFlex для сохранения естественных гормонов роста, цитокинов и внеклеточного матрикса (ECM ).

Отчет DBMR о мировом рынке гелей для ран дает вам ценную информацию, которая может помочь в принятии нескольких важных бизнес-решений. На основе наших отчетов и исследовательского опыта вы можете создать реалистичные стратегии роста для вашего бизнеса.    

SKU-26512